Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Risk of Head and Neck Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02923258
What this trial is testing

Postoperative CCRT With Docetaxel vs Cisplatin in High Risk Oral Cavity Cancer

Who this might be right for
Oral Cavity Squamous Cell Carcinoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 224
Testing effectiveness (Phase 2)UnknownNCT03904225
What this trial is testing

Tegio Consolidation Therapy for NPC Patients With High Risk of Metastasis

Who this might be right for
Nasopharyngeal Carcinoma
Zhejiang Cancer Hospital 220
Large-scale testing (Phase 3)Temporarily pausedNCT01810913
What this trial is testing

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Who this might be right for
Oropharyngeal p16INK4a-Negative Squamous Cell CarcinomaStage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7+6 more
National Cancer Institute (NCI) 613
Not applicableUnknownNCT02627807
What this trial is testing

Clinical Target Volume Based on Disease Extension Risk Atlas and Computer-aided Delineation in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Neoplasms
Sun Yat-sen University 386
Testing effectiveness (Phase 2)Looking for participantsNCT07290621
What this trial is testing

Toripalimab in Combination With Standard Treatment for Human Papillomavirus (HPV) Positive Throat Cancer

Who this might be right for
Oropharyngeal Cancer
University of Chicago 30
Large-scale testing (Phase 3)WithdrawnNCT03673735
What this trial is testing

Maintenance Immune Check-point Inhibitor Following Post-operative Chemo-radiation in Subjects With HPV-negative HNSCC

Who this might be right for
Squamous Cell Head and Neck Carcinoma
European Organisation for Research and Treatment of Cancer - EORTC
Testing effectiveness (Phase 2)Study completedNCT04260126
What this trial is testing

Study of PDS0101 and Pembrolizumab Combination I/O in Subjects With HPV16 + Recurrent and/or Metastatic HNSCC

Who this might be right for
Metastatic Head and Neck CancerRecurrent Head and Neck CancerHPV Positive Oropharyngeal Squamous Cell Carcinoma+1 more
PDS Biotechnology Corp. 95
Not applicableEnded earlyNCT05480891
What this trial is testing

Transnasal Esophagoscopy (TNE) Esophageal Cancer Screening

Who this might be right for
Esophageal Cancer
University of Illinois at Chicago 3
Early research (Phase 1)Study completedNCT02107235
What this trial is testing

Platinum-based Chemoradiotherapy and Rigosertib in Head and Neck Cancer

Who this might be right for
Head and Neck NeoplasmsCarcinoma, Squamous Cell
Traws Pharma, Inc. 2
Large-scale testing (Phase 3)Active Not RecruitingNCT03811015
What this trial is testing

Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer

Who this might be right for
Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
National Cancer Institute (NCI) 636
Testing effectiveness (Phase 2)UnknownNCT04126460
What this trial is testing

High-risk Recurrent or Second Primary HNSCC With PD-1 Antibody Adjuvant After Salvage Surgery(RePASS)

Who this might be right for
Head and Neck Cancer
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 41
Not applicableNot Yet RecruitingNCT07056218
What this trial is testing

Outcome of RAI131 Therapy in Patients With Differentiated Thyroid Cancer (Low and Intermediate Risk)

Who this might be right for
Thyroid Cancer
Sohag University 50
Not applicableStudy completedNCT01647425
What this trial is testing

Alcohol and Tobacco Consumption in Patients With Head and Neck or Lung Cancer

Who this might be right for
Head and Neck CancerLung Cancer
Centre Oscar Lambret 385
Not applicableStudy completedNCT00963326
What this trial is testing

Study of Blood and Tissue Samples From Patients With Larynx Cancer, Pharynx Cancer, or Oral Cavity Cancer

Who this might be right for
Head and Neck Cancer
Centre Oscar Lambret 30
Large-scale testing (Phase 3)Active Not RecruitingNCT03576417
What this trial is testing

A Trial Evaluating the Addition of Nivolumab to Cisplatin-RT for Treatment of Cancers of the Head and Neck

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
Groupe Oncologie Radiotherapie Tete et Cou 680
Not applicableEnrolling By InvitationNCT06261190
What this trial is testing

Active Surveillance for Low-risk Papillary Thyroid Carcinoma

Who this might be right for
Thyroid CancerPapillary Thyroid Carcinoma
National Cancer Center, Korea 499
Testing effectiveness (Phase 2)Active Not RecruitingNCT05108870
What this trial is testing

TheraT® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers

Who this might be right for
Human Papilloma VirusHPVHPV Positive Oropharyngeal Squamous Cell Carcinoma+1 more
University of Chicago 35
Testing effectiveness (Phase 2)Study completedNCT03330249
What this trial is testing

Comparison of Two Concomitant Administration of RT With Cisplatin in Standard Infusion or Fractional Infusion

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Groupe Oncologie Radiotherapie Tete et Cou 124
Large-scale testing (Phase 3)Study completedNCT02633202
What this trial is testing

Concurrent Chemotherapy for the Intermediate Risk Nasopharyngeal Carcinoma In Intensity-modulated Radiotherapy Era

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 338
Not applicableStudy completedNCT00897273
What this trial is testing

Oral HPV Infection in Young Men

Who this might be right for
Head and Neck CancerInfectionPrecancerous Condition
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 500
Next Page